CAS 317353-73-4

(S)-2-(1-(4-(2-(4-(3-(o-Tolyl)ureido)phenyl)acetyl)morpholine-3-carbonyl)piperidin-4-yl)acetic acid

CAS : 317353-73-4

(S)-2-(1-(4-(2-(4-(3-(o-Tolyl)ureido)phenyl)acetyl)morpholine-3-carbonyl)piperidin-4-yl)acetic acid

Degré de pureté : 99%

Masse moléculaire : 522.6g/mol

Ref: 54-OR1066763

TCS 2314

CAS : 317353-73-4

TCS 2314 is a compound that has been shown to have an effect on cancer cells. TCS 2314 was synthesized and characterized as a potential anticancer drug. It is a small molecule with the structure of a carboxylate, which binds to chemokines expressed by cancer cells. Binding of TCS 2314 to chemokines inhibits their ability to bind to receptors on white blood cells, preventing them from being recruited into the tumor environment. The molecular modeling studies indicate that TCS 2314 may also inhibit selectins from binding to leukocytes, which are necessary for the recruitment of monocytes into tumors.

Formule : C₂₈H₃₄N₄O₆

Degré de pureté : Min. 95%

Masse moléculaire : 522.59 g/mol

Ref: 3D-SMA35373

TCS 2314

CAS : 317353-73-4

TCS 2314 is an orally active and selective very late antigen-4 antagonist (IC50: 4.4 nM).

Formule : C₂₈H₃₄N₄O₆

Degré de pureté : 98%

Couleur et forme : Solid

Masse moléculaire : 522.59

Ref: TM-T17020